Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001140361-25-046787

CFO sold 406,731 shares at an average $22.43 ($9,122,307)

  • CFO acquired 260,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Pulik Richard CFO 2025-12-23 Option exercise +260,000 $3.85 $1,001,000 646,144 D
Pulik Richard CFO 2025-12-23 Sale −260,000 $22.45 $5,837,000 386,144 D
Pulik Richard CFO 2025-12-23 Sale −146,731 $22.39 $3,285,307 239,413 D
Derivatives
Pulik Richard CFO 2025-12-23 Option exercise · Stock Option (Right to Buy) −260,000 740,000 D
Open-market sales · 406,731 sh · avg $22.43 · $9,122,307
Loading xslF345X05/form4.xml…